What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary areas of study are Cancer, Internal medicine, Incidence, Risk factor and Cancer registry.
Jørgen H. Olsen has researched Cancer in several fields, including Epidemiology, Cohort study and Cohort.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Surgery, Oncology and Pathology.
Jørgen H. Olsen combines subjects such as Lung cancer, Carcinoma and Pediatrics with his study of Incidence.
His Risk factor research includes elements of Immunology, Relative risk, Semen and Standardized mortality ratio.
His work deals with themes such as Liver cancer and Survival rate, which intersect with Cancer registry.
His most cited work include:
- Prognosis of cancers associated with venous thromboembolism. (1133 citations)
- Cancer Incidence in a Population-Based Cohort of Patients Hospitalized With Diabetes Mellitus in Denmark (534 citations)
- The Risk of a Diagnosis of Cancer after Primary Deep Venous Thrombosis or Pulmonary Embolism (510 citations)
What are the main themes of his work throughout his whole career to date?
Jørgen H. Olsen mainly focuses on Cancer, Internal medicine, Incidence, Cohort study and Surgery.
His Cancer study integrates concerns from other disciplines, such as Epidemiology, Cohort and Risk factor.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.
Jørgen H. Olsen specializes in Incidence, namely Standardized mortality ratio.
His work investigates the relationship between Cohort study and topics such as Pediatrics that intersect with problems in Young adult and Disease.
His studies deal with areas such as Aspirin, Kidney cancer and Occupational medicine as well as Surgery.
He most often published in these fields:
- Cancer (52.03%)
- Internal medicine (47.15%)
- Incidence (30.35%)
What were the highlights of his more recent work (between 2010-2019)?
- Cancer (52.03%)
- Internal medicine (47.15%)
- Pediatrics (18.16%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer, Internal medicine, Pediatrics, Cohort study and Cohort.
The Cancer study combines topics in areas such as Radiation therapy and Incidence.
His work carried out in the field of Incidence brings together such families of science as Dermatology, Relative risk, Surgery and Poisson regression.
Jørgen H. Olsen interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine.
His Pediatrics research incorporates elements of Absolute risk reduction, Young adult, Liver disease, Disease and Transplantation.
His research in Cohort study intersects with topics in Cirrhosis and Confidence interval.
Between 2010 and 2019, his most popular works were:
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 (204 citations)
- Use of mobile phones and risk of brain tumours: update of Danish cohort study (135 citations)
- European Code against Cancer 4th edition: 12 ways to reduce your cancer risk § (99 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Cancer, Cohort study, Cohort, Pediatrics and Internal medicine are his primary areas of study.
His research in the fields of Breast cancer, Cancer registry, Cancer prevention and Cervical cancer overlaps with other disciplines such as Evidence-based medicine.
His Cohort study study incorporates themes from Surgery and Incidence.
His research in Surgery focuses on subjects like Oncology, which are connected to Skin cancer.
His Cohort research focuses on Standardized mortality ratio in particular.
His study in the fields of Case-control study, Vagotomy and Parkinson's disease under the domain of Internal medicine overlaps with other disciplines such as Text mining and Vagal nerve.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
